newsfilter
← Latest News
GlobeNewswire·

IsoPlexis' Immune Monitoring Helps Identify Early Factors of Long COVID in Cell Publication

BRANFORD, Conn., Feb. 10, 2022 (GLOBE NEWSWIRE) -- IsoPlexis Corporation (NASDAQ:ISO), the Superhuman Cell Company, today announced the publication of a study in Cell, led by the Institute for Systems Biology and Seattle COVID consortium, in which re